jagomart
digital resources
picture1_Exposure Response Prevention Pdf 108222 | Repub 122522 O A


 158x       Filetype PDF       File size 0.84 MB       Source: repub.eur.nl


File: Exposure Response Prevention Pdf 108222 | Repub 122522 O A
melchior et al trials 2019 20 277 https doi org 10 1186 s13063 019 3381 9 study protocol open access metacognitive therapy versus exposure and response prevention for obsessive compulsive ...

icon picture PDF Filetype PDF | Posted on 27 Sep 2022 | 3 years ago
Partial capture of text on file.
                Melchior et al. Trials          (2019) 20:277 
                https://doi.org/10.1186/s13063-019-3381-9
                 STUDY PROTOCOL                                                                                             Open Access
                Metacognitive therapy versus exposure
                and response prevention for obsessive-
                compulsive disorder: study protocol for
                a randomized controlled trial
                              1*                   2                3                              1
                Kim Melchior , Ingmar Franken , Mathijs Deen and Colin van der Heiden
                 Abstract
                 Background: The recommended psychological treatment of choice for obsessive-compulsive disorder (OCD) is
                 exposure with response prevention (ERP). However, recovery rates are relatively modest, so better treatments are
                 needed. This superiority study aims to explore the relative efficacy of metacognitive therapy (MCT), a new form
                 of cognitive therapy based on the metacognitive model of OCD.
                 Design and method: In a randomized controlled trial, we will compare MCT with ERP. One hundred patients
                 diagnosed with OCD will be recruited in an outpatient mental health center in Rotterdam (the Netherlands). The
                 primary outcome measure is OCD severity, measured by the Yale-Brown Obsessive Compulsive Scale (Y-BOCS).
                 Data are assessed at baseline, after treatment, and at 6 and 30months follow-up.
                 Discussion: By comparing MCT with ERP we hope to provide an indication whether MCT is efficacious in the
                 treatment of OCD and, if so, whether it has the potential to be more efficacious than the current “gold standard”
                 psychological treatment for OCD, ERP.
                 Trial registration: Dutch Trial Register, NTR4855. Registered on 21 October 2014.
                 Keywords: Obsessive-compulsive disorder, Metacognitive therapy, Exposure and response prevention, Randomized
                 controlled trial
                Background                                                        modalities in reducing symptoms of OCD [3]. The
                Phenomenology and treatment                                       first-choice psychological treatment for OCD is exposure
                Obsessive-compulsive disorder (OCD) is a severe mental            and response prevention (ERP) [31, 34, 37], a specific
                condition which is characterized by intrusive thoughts            type of cognitive behavioral therapy (CBT) based on
                (obsessions)   and repetitive     behaviors    (compulsions)      learning theory, which suggests that classical condition-
                intended to neutralize anxiety induced by these thoughts          ing is responsible for the development of obsessions,
                [1]. OCD has been ranked among the 10 most debilitat-             whereas operant conditioning processes maintain anxiety
                ing disorders by the World Health Organization (WHO)              and compulsive behaviors [27]. In ERP treatment, patients
                and tends to be chronic without adequate treatment                are exposed to anxiety-provoking stimuli (situations, ob-
                [48]. Both studies into pharmacological treatment, pri-           jects, thoughts) combined with the strict prevention of
                marily   with selective serotonin reuptake inhibitors             performing ritual behaviors [26]. Since its introduction in
                (SSRIs), and studies into specific forms of psychological         1966, the prognosis for OCD improved substantially.
                treatment supported the effectiveness of these treatment          However, OCD remains a difficult disorder to treat.
                                                                                  Although numerous studies have found statistically signifi-
                * Correspondence: k.melchior@psyq.nl                              cant change and large improvements in OCD symptoms
                1                                                                 after ERP, the outcomes are sub-optimal for the majority
                Outpatient Treatment Centre PsyQ & Erasmus University Rotterdam, Max
                Euwelaan 70, 3062 MA Rotterdam, the Netherlands                   of patients. More specifically: although about 60% of
                Full list of author information is available at the end of the article
                                                 ©The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
                                                 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
                                                 reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
                                                 the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
                                                 (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
               Melchior et al. Trials          (2019) 20:277                                                                    Page 2 of 11
               treatment completers achieve recovery, only approxi-            thought object fusion (TOF). TAF [32] refers to the belief
               mately 25% of patients are asymptomatic following treat-        that obsessional thoughts can lead to the commission of an
               ment [11, 14], which means that the majority of patients        action (e.g. “thinking about killing someone will make me
               treated with ERP continue to experience distressing OCD         do it”). TEF [42] refers to the belief that obsessional
               symptoms. Furthermore, the overall effectiveness of ERP         thoughts can make events happen (e.g. “thinking about a
               for OCD is attenuated by some limitations of the                car accident means I will be involved in such an accident”)
               approach. As approximately 30% of patients with OCD             or mean an event has already occurred (e.g. “If I think I ran
               refuse ERP or drop out from treatment prematurely, it is        into someone with my car, I probably did it”). Finally, TOF
               assumed that overall recovery rates are lower [30]. More-       [43] refers to the belief that thoughts or negative feelings
               over, these figures suggest that ERP might be hard to           can be passed into objects (e.g. “my feeling of evil could be
               tolerate and is burdensome, which is supported by the           passed into objects and from these objects to other
               finding that an important reason for not attempting ERP         people”). Once the fusion beliefs are activated, they give
               are the requirements of treatment (e.g. exposure to             significance to obsessional thoughts and lead to appraisal
               anxiety provoking stimuli [46]). So, although it can be         of, and worrying about, the thoughts and consequently to
               concluded that ERP is efficacious, there is clearly room for    feelings of anxiety and perceived threat. This anxiety primes
               improvement in the psychological treatment of OCD. It is        a second domain of metacognitive beliefs: beliefs about the
               assumed that this improvement could result from a better        necessity of performing rituals in response to obsessive
               understanding in the mechanisms involved in the main-           thoughts in order to reduce the perceived threat (e.g.
               tenance of the disorder.                                        “Counting to seven will restrain me from acting on my
                                                                               thoughts”). Consequently, patients with OCD engage in
               The metacognitive model of OCD                                  both overt and covert ritual behaviors and, thereby, use
               A recently developed theoretical account explaining the         specific internal rules (instead of external observation) and
               maintenance of OCD symptoms is the metacognitive                so-called “stop signals” to determine how the ritual must be
               model by Adrian Wells [42, 43]. In this model of OCD, two       conducted and when it can be terminated. Such stop sig-
               belief domains are assumed to be fundamental in the main-       nals are often metacognitive experiences, such as a feeling
               tenance of the disorder. First, it is proposed that obsessions  of satisfaction (e.g. “I must wash my hands until ‘it feels
               are misinterpreted because of metacognitive beliefs about       right’”). They also use other neutralizing coping strategies
               the dangerousness, significance, and consequences of intru-     such as monitoring for further intrusive experiences, which
               sive thoughts and feelings, the so-called fusion beliefs.       is seen as a counterproductive strategy as it increases the
               Three classes of fusion beliefs are highlighted: thought        awareness and frequency of intrusive thoughts. The meta-
               action fusion (TAF); thought event fusion (TEF); and            cognitive model of OCD is illustrated in Fig. 1.
                 Fig. 1 Metacognitive model for OCD [42]
                Melchior et al. Trials          (2019) 20:277                                                                       Page 3 of 11
                Metacognitive treatment for OCD                                  al. [39] found statistically significant reductions on all out-
                Based on the metacognitive model, treatment should               come variables. Moreover, in terms of clinically significant
                focus exclusively on modifying patients’ beliefs about the       results, 74% of the treatment completers (n=19) were
                importance and power of intrusive thoughts and the               classified as recovered after treatment and 47% as asymp-
                necessity of performing rituals, instead of challenging          tomatic. At follow-up, this increased to 80% and 67% re-
                the actual content of the obsessions and compulsions             spectively. Finally, Simons et al. [35] found positive
                [12]. Although metacognitive therapy (MCT) uses com-             outcomes of MCT in comparison to ERP in the treatment
                parable techniques as cognitive therapy (CT) for this            of pediatric OCD in a case series design. Together, these
                purpose, such as verbal reattribution and behavioral             findings suggest that MCT might be an efficacious treat-
                experiments, the two approaches are fundamentally dif-           ment for OCD and deserves controlled evaluation. The
                ferent [13]. For example, patients with OCD can describe         present trial has been initiated to compare the relative
                appraisals in the domain of inflated responsibility, perfec-     efficacy of MCT with ERP, in an outpatient clinical sample
                tionism, and intolerance of uncertainty. The metacognitive       of patients with OCD. Our main hypothesis is that
                model proposes that such appraisals result from the acti-        MCT is more efficacious than ERP in the treatment
                vation of metacognitive beliefs about obsessions; con-           of OCD in terms of both statistically and clinically
                sequently, it is not necessary to modify these lower order       significant improvements, both directly after treatment
                beliefs as is done in CT (e.g. by using the pie chart tech-      (primary outcome) and at follow-up.
                nique to compare the patient’s original estimated proba-
                bility with a more realistic estimate of probability) [5, 17].   Design and methods
                Targeting such lower order beliefs and automatic thoughts        Design
                is seen as counterproductive as it just promotes further         We will conduct a randomized controlled trial (RCT)
                conceptual processing, such as worrying and rumination           with a pretest–post-test (primary outcome) 6-month–
                [15]. Instead, it is thought that modification of the meta-      30-month follow-up-design. Patients will be recruited
                cognitive beliefs about the meaning and power of obses-          from consecutive referrals to the Anxiety Disorders
                sions removes the need for further conceptual processing.        department of PsyQ, an outpatient community mental
                Therefore, interventions are explicitly aimed at the meta-       health center in the Netherlands. After screening for
                cognitive processes which perpetuate the continued               eligibility and informed consent, we will randomize the
                maladaptive processing instead of attempting to modify           patients into two groups: MCTand ERP. The number of
                the content of perseverative thinking (i.e. appraisals) [13].    excluded patients and refusers and their reasons are
                  So far, there is preliminary evidence supporting the           registered. Participating patients will be assessed by
                efficacy of MCT for OCD. The clinical significance of            self-report measures and semi-structured clinical inter-
                treatment effects in the following mentioned studies is          views administered by a research assistant who is blind
                calculated using the standard criteria developed by Fisher       to group allocation at entry (pre-treatment), after the last
                and Wells [11, 14], based on the method of Jacobson and          treatment session (post-treatment – primary outcome),
                Truax [21]. Based on these criteria, patients are classified     six months (first follow-up) after treatment completion
                as recovered if they achieved a reduction of minimal 10          and 30months (second follow-up) after treatment has
                points on the Yale-Brown Obsessive Compulsive Scale              ended. The latter assessment is included to answer a
                (Y-BOCS[19]; a semi-structured interview for OCS) and a          secondary research questions on the durability of both
                post-treatment score <14. When achieving a post-treat-           the ERP and MCT effect on the long term. Due to a
                ment score <7, patients are classified as asymptomatic.          lack of studies with follow-up periods of >1 year [9, 47],
                Using single case methodology, Fisher and Wells [12]             the information on longer-term effects are unknown. In
                found clinically significant improvements for four OCD           case of drop-out, measurements and interviews are also
                patients with different clinical presentations who were          administered directly after treatment had ended whenever
                treated individually with MCT. Two of the four parti-            this is possible. The study has received ethical approval
                cipants were asymptomatic at both post-treatment and             from the Medical Ethical Committee of the Leiden
                three-monthfollow-up assessments. Furthermore, Rees              University Medical Centre (LUMC) (protocol number
                and Van Koesveld [33] found that seven out of eight              NL50201.058.14) and is registered in the Dutch Trial
                participants in an open trial of group MCT for OCD               Register (protocol number NTR4855). All data will be
                reached criteria for a recovery status on the Y-BOCS at          stored anonymously; there is a data safety and monitoring
                three-monthfollow-up (87.5%). In an additional study, Fitt       board for the study. Figure 2 shows a flowchart of the
                and Rees [16] found similar clinically significant reduc-        study from patient enrollment up to data analysis and
                tions among three patients treated with MCT using video-         reporting. This study follows the “guidance of standard
                conference. In an open trial of individual metacognitive         protocol items: recommendations of interventional study’s
                therapy among 25 patients with OCD, Van der Heiden et            (SPIRIT).” The SPIRIT figure template is displayed in
                  Melchior et al. Trials          (2019) 20:277                                                                                        Page 4 of 11
                                                                       Entry at PsyQ
                                                                                                             Participants are excluded if 
                                                                                                             they:
                                                          Intake phase. Semi structured interview            1) meet DSM-IV criteria for 
                                                                     using the SCID-I                        major depressive disorder or 
                                                                                                             substance use disorders 
                                                                                                             (other than smoking) that 
                                                                                                             needs immediately treatment 
                                                                   Assessed for eligibility                  2) meet DSM-IV criteria for 
                                                        Inclusion criteria are:                              psychotic or bipolar disorder.
                                                        1) Primary diagnosis of OCD                          have mental impairment or 
                                                        2) Seeking treatment for OCD                         organic brain disorder.
                                                        3) Age 18-65.                                        3) have started medication or 
                                                                                                             have a change in medication 
                                                                                                             type or dose in the 6 weeks 
                                                                                                             before treatment, or during 
                                                        Potential participants receive information           treatment.
                                                        about the design and procedures of the 
                                                        study, both verbally and written.
                                                                     Informed consent                        Refusers are offered treatment 
                                                                                                             as usual, which is exposure 
                                                                                                             and response prevention at 
                                                                                                             the Anxiety Disorders
                                                                                                             Department of PsyQ.
                                                                 Pretreatment assessment
                                                                      Randomization
                                         Allocated to metacognitive                        Allocated to exposure and 
                                         therapy (n=50)                                    response prevention (n=50)
                                         Posttreatment assessment                          Posttreatment assessment
                                         (primary outcome)                                 (primary outcome)
                                         Follow-up assessment 1                            Follow-up assessment 1
                                         (6 months after treatment                         (6 months after treatment 
                                         completion)                                       completion)
                                         Follow-up assessment 2                            Follow-up assessment 2
                                         (30 months after treatment                        (30 months after treatment 
                                         completion)                                       completion)
                                                                     Data analysis and reporting
                   Fig. 2 Flowchart of the study
                  Fig. 3. In addition, the SPIRIT checklist can be found in                  between-group effect (Cohen’s d=0.5 [6]) from baseline
                  Additional file 1.                                                         to post-treatment. We chose for this medium between-
                                                                                             group effect because expecting a larger difference between
                  Sample size                                                                the two treatment groups does seem unrealistic since
                  There are no studies available directly comparing ERP                      numerous studies have found statistically significant
                  with MCT. We chose to design our study with enough                         change and large improvements in OCD symptoms after
                  statistical  power to enable us to detect a medium                         ERP. On the other hand, designing our study to enable us
The words contained in this file might help you see if this file matches what you are looking for:

...Melchior et al trials https doi org s study protocol open access metacognitive therapy versus exposure and response prevention for obsessive compulsive disorder a randomized controlled trial kim ingmar franken mathijs deen colin van der heiden abstract background the recommended psychological treatment of choice ocd is with erp however recovery rates are relatively modest so better treatments needed this superiority aims to explore relative efficacy mct new form cognitive based on model design method in we will compare one hundred patients diagnosed be recruited an outpatient mental health center rotterdam netherlands primary outcome measure severity measured by yale brown scale y bocs data assessed at baseline after months follow up discussion comparing hope provide indication whether efficacious if it has potential more than current gold standard registration dutch register ntr registered october keywords modalities reducing symptoms phenomenology first severe specific condition whic...

no reviews yet
Please Login to review.